Zoetis (ZTS) Treasury Shares (2013 - 2026)
Zoetis' (ZTS) quarterly Treasury Shares came in at $11.3 billion in Q1 2026, up 2425.28% year-on-year from $447.0 million in Q1 2025, and up 5.64% on a QoQ basis from $10.7 billion in Q4 2025.
Zoetis (ZTS) Treasury Shares (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 12 years of Treasury Shares data on file, last reported at $11.3 billion in Q1 2026.
- On a quarterly basis, Treasury Shares rose 2425.28% year-over-year to $11.3 billion in Q1 2026; TTM through Mar 2026 was $11.3 billion, a 2425.28% increase from a year earlier, with the FY2025 full-year figure at $10.7 billion, up 43.52% from the prior year.
- Treasury Shares for Q1 2026 stood at $11.3 billion, up from $10.7 billion in the prior quarter.
- Over the last five years, Treasury Shares for ZTS reached as high as $81.5 million in Q1 2026 and fell as low as $30.7 million in Q1 2022.
- Historically, Treasury Shares has averaged $49.0 million across 5 years, with a median of $44.9 million in 2024.
- Across the five-year window, Treasury Shares sank 93.91% in 2023 and surged 2425.28% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $4.5 billion in 2022, then grew by 23.31% to $5.6 billion in 2023, then jumped by 33.02% to $7.4 billion in 2024, then soared by 43.52% to $10.7 billion in 2025, then grew by 5.64% to $11.3 billion in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $11.3 billion in Q1 2026, $10.7 billion in Q4 2025, and $8.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 59.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.29 Bn |
| Mar 31, 2026 | 11.29 Bn |
| Mar 31, 2026 | 81.54 Mn |
| Mar 31, 2026 | 81.54 Mn |
| Dec 31, 2025 | 10.69 Bn |
| Dec 31, 2025 | 76.96 Mn |
| Dec 31, 2025 | 76.96 Mn |
| Dec 31, 2025 | 10.69 Bn |
| Sep 30, 2025 | 8.61 Bn |
| Sep 30, 2025 | 8.61 Bn |
| Sep 30, 2025 | 60.43 Mn |
| Sep 30, 2025 | 60.43 Mn |
| Jun 30, 2025 | 57.90 Mn |
| Jun 30, 2025 | 8.23 Bn |
| Jun 30, 2025 | 8.23 Bn |
| Jun 30, 2025 | 57.90 Mn |
| Mar 31, 2025 | 55.80 Mn |
| Mar 31, 2025 | 55.80 Mn |
| Mar 31, 2025 | 447.00 Mn |
| Mar 31, 2025 | 447.00 Mn |